» Introduction
» Program
» Abstract
» Speakers
» Sponsors
» Map
» Registration
 
 
 

September 2nd: Approx 13:30-20:05
September 3rd: Approx 08:45-15:30


Topics:
  • The intestinal microflora
  • Dyspepsia and gastric reflux disease (GERD)
  • Probiotics and Helicobacter pylori gastritis
  • Probiotics, diet and gastric cancer (including antiox. aspects)
  • Pediatric acute and chronic diarrhoea
  • Irritable bowel syndrome
  • Probiotics to combat infections and allergy
  • Probiotics in IBD (inflammatory bowel diseases)
  • Intestinal translocation
  • Prospects for probiotic and food-based vaccines
  • Probiotics as functional food and/or medicine
  • Clinical trials to document probiotics
  • Safety aspect on probiotics

Round Table Discussions:
  • Clinical trial designs; Guidelines in various EU-countries, North America and Japan today and tomorrow.
  • When is a probiotic a food or a drug?
  • How to encourage basic and clinical research and trials on promising pro-, pre and synbiotics?
  • What is the role of research in universities and collaborations with food and drug industries?

 
 
Time Topic Speaker 1 Speaker 2
September 2 Venue: WTC, Stockholm    
13.30-13.45 Chair: Tore Midvedt
Welcome address
Torkel Wadström, Lund, Sweden, and EHSG  
13.45-14.40 The intestinal microflora James Versalovic, Houston, USA Göran Molin, Lund, Sweden
14.40-15.35 Dyspepsia and gastric reflux disease (GERD) Lars Lundell, Karolinska institute, Huddinge, Sweden Franco Bazzoli, Bologna, Italy
15.35-16.15 Break, posters    
16.15-17.10 Probiotics and Helicobacter pylori gastritis Antonio Gasbarrini, Rome, Italy Yasuhiro Koga
Kanagawa, Japan
17.10-18.05 Probiotics, diet and gastric cancer (including antiox. aspects) Theodore Rokkas, Athens, Greece Elisabeth Norin, Karolinska Institute, Stockholm, Sweden
18.05-18.30 Refreshments    
18.30-19.05 Pediatric acute and chronic diarrhoea Merja Ashorn, Tampere, Finland  
19.05-19.40 Irritable bowel syndrome Jennifer Madden, Dundee, UK  
19.40-20.00 Report from the ISAPP probiotic society Gregor Reid, London, Canada  
20.05- Buffet dinner    
Sept 3 Venue: Swedish Society of Medicine    
08.45-09.40 Chair: Bengt Björksten
Probiotics to combat infections and allergy
Marika Mikelsaar, Tartu, Estonia Agnes Wold, Gothenburg
09.40-10.05 Probiotics in IBD (inflammatory bowel diseases) P. Heczko, Krakow, Poland  
10.05-10.25 Coffee break    
10.25-11.20 Intestinal translocation Bengt Jeppsson, Malmö, Sweden Tore Midtvedt, Stockholm, Sweden
11.20-11.40 Prospects for probiotic and food-based vaccines Pierre Michetti, University of Lausanne, CH  
11.40-12.00 Chair: Nils-Georg Asp
SNF, Lund Sweden
Probiotics as functional food and/or medicine
Åke Bruce, Natl Food Administration, Uppsala, Sweden  
12.00-12.20 Clinical trials to document probiotics Arne Melander, Malmö, Sweden  
12.20-12.40 Safety aspect on probiotics Seppo Salminen, University of Turkku, Finland  
12.40-13.40 Lunch    
13.40-14.00 Health claims for functional
foods in Japan
Takashi Sasaki, Tokyo, Japan  
14.00-15.30 Chair:
Seppo Salminen, Turkku, Finland

Panel discussion with participation from the audience:

Documentation of effects of probiotics as functional foods and medicinal products

Participants:
Gunnar Alvan, Director General, MPA, Sweden

Franco Bazzoli, Italy

Åke Bruce, Sweden

Tore Midtvedt.

Nils-Georg Asp

Yasuhiro Koga, Japan

to be announced